BSE Live
Oct 17, 16:01Prev. Close
921.35
Open Price
922.15
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Oct 17, 15:57Prev. Close
921.75
Open Price
914.30
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
927.20 (18)
Key Financial Ratios of Windlas Biotech (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | |
Per Share Ratios | |||||
Basic EPS (Rs.) | 29.19 | 27.97 | 19.70 | 18.58 | |
Diluted EPS (Rs.) | 28.87 | 27.88 | 19.70 | 18.58 | |
Cash EPS (Rs.) | 42.45 | 34.44 | 26.28 | 23.05 | |
Book Value [ExclRevalReserve]/Share (Rs.) | 241.30 | 216.34 | 192.24 | 181.14 | |
Book Value [InclRevalReserve]/Share (Rs.) | 241.30 | 216.34 | 192.24 | 181.14 | |
Revenue from Operations/Share (Rs.) | 362.54 | 303.37 | 245.19 | 213.79 | |
PBDIT/Share (Rs.) | 53.49 | 44.06 | 33.54 | 27.13 | |
PBIT/Share (Rs.) | 40.14 | 37.60 | 27.63 | 21.56 | |
PBT/Share (Rs.) | 38.05 | 37.07 | 27.26 | 20.91 | |
Net Profit/Share (Rs.) | 29.10 | 27.98 | 20.37 | 17.48 | |
NP After MI And SOA / Share (Rs.) | 28.84 | 27.86 | 20.37 | 17.48 | |
Profitability Ratios | |||||
PBDIT Margin (%) | 14.75 | 14.52 | 13.68 | 12.69 | |
PBIT Margin (%) | 11.07 | 12.39 | 11.27 | 10.08 | |
PBT Margin (%) | 10.49 | 12.21 | 11.11 | 9.77 | |
Net Profit Margin (%) | 8.02 | 9.22 | 8.30 | 8.17 | |
NP After MI And SOA Margin (%) | 7.95 | 9.18 | 8.30 | 8.17 | |
Return on Networth/Equity (%) | 11.95 | 12.87 | 10.59 | 9.64 | |
Return on Capital Employed (%) | 16.46 | 17.20 | 14.18 | 11.83 | |
Return on Assets (%) | 7.94 | 9.25 | 8.05 | 7.75 | |
Total Debt/Equity (X) | 0.05 | 0.00 | 0.00 | 0.02 | |
Asset Turnover Ratio (%) | 1.10 | 1.09 | 1.01 | 1.18 | |
Liquidity Ratios | |||||
Current Ratio (X) | 2.11 | 2.51 | 2.92 | 4.02 | |
Quick Ratio (X) | 1.78 | 2.15 | 2.30 | 3.39 | |
Inventory Turnover Ratio (X) | 10.52 | 5.65 | 5.11 | 6.14 | |
Dividend Payout Ratio (NP) (%) | 19.01 | 14.35 | 17.89 | 0.00 | |
Dividend Payout Ratio (CP) (%) | 12.99 | 11.65 | 13.87 | 0.00 | |
Earnings Retention Ratio (%) | 80.99 | 85.65 | 82.11 | 0.00 | |
Cash Earnings Retention Ratio (%) | 87.01 | 88.35 | 86.13 | 0.00 | |
Coverage Ratios | |||||
Interest Coverage Ratios (%) | 25.59 | 82.93 | 89.07 | 41.73 | |
Interest Coverage Ratios (Post Tax) (%) | 25.59 | 82.93 | 89.07 | 41.73 | |
Valuation Ratios | |||||
Enterprise Value (Cr.) | 2,193.55 | 1,034.75 | 446.24 | 350.19 | |
EV/Net Operating Revenue (X) | 2.89 | 1.64 | 0.87 | 0.75 | |
EV/EBITDA (X) | 19.56 | 11.29 | 6.36 | 5.92 | |
MarketCap/Net Operating Revenue (X) | 2.87 | 1.69 | 0.92 | 0.98 | |
Retention Ratios (%) | 80.98 | 85.64 | 82.10 | 0.00 | |
Price/BV (X) | 4.31 | 2.37 | 1.17 | 1.16 | |
Price/Net Operating Revenue | 2.87 | 1.69 | 0.92 | 0.98 | |
Earnings Yield | 0.03 | 0.05 | 0.09 | 0.08 |
10.09.2025
Windlas Biotech Standalone June 2025 Net Sales at Rs 210.09 crore, up 19.95% Y-o-Y
27.05.2025
Windlas Biotech Consolidated March 2025 Net Sales at Rs 202.71 crore, up 18.34% Y-o-Y
23.05.2025
Windlas Biotech Standalone March 2025 Net Sales at Rs 202.71 crore, up 18.34% Y-o-Y
17.02.2025
Windlas Biotech Standalone December 2024 Net Sales at Rs 195.02 crore, up 20.22% Y-o-Y